SH/EAHP 2007 Workshop - Progress in T-cell and NK cell Malignancies - title graphic

Cases by Session

Cases by Contact Submitter

Submitter Contact Information

Session: Ph- chronic myeloproliferative disease
Case number: 081

Submitter(s): Beverly P. Nelson, Lo Ann Peterson.

Clinical history
A 38 year-old-man went to see his doctor in June 2004 because of neck pain. The physical examination was normal, MRI showed mild degenerative changes, and a CBC showed leukocytosis. He was referred to a hematologist. CBC with differential showed the following: WBC 68.3k/uL; HGB 12.1 g/dl; HCT 37.9%; MCV 98fL; RDW 15.9%; PLT 91k/uL (myelocytes 6.5%, metamyelocytes 10.0%, neutrophils 67%; lymphocytes 7.5%, monocytes 4.0%, eosinophils 4.5%, basophils 1.0%). Leukocyte alkaline phosphatase score performed on the blood was decreased (LAP 2; Reference range 18-164). A bone marrow biopsy showed findings consistent with a chronic myeloproliferative disorder.

Details of gross/microscopic pathology:
Wright/Giemsa stained blood and bone marrow touch imprint were reviewed. The aspirate smear contained no cellular particles. The bone marrow core biopsy was fixed in B5 and decalcified. H&E and reticulin stains were performed.

Immunophenotype (flow cytometry/immunohistochemistry):
Not performed.

Cytogenetics:
Genetic analysis of the bone marrow showed an abnormal karytoytpe:
46XY, t(5;12) (q33;p13)[20].
FISH identified PDGFRb/TEL fusion and showed no BCR/ABL fusion.


Molecular analysis:


Interesting feature(s) of submitted case:
Many of the blood and bone marrow findings in this case resemble CML, but thrombocytopenia would be unusual and BCR/ABL translocation was absent. Instead t(5;12)(q33;p13) resulting in TEL/PDGFbeta gene fusion was present. Translocation (5;12) has been described in CMML; monocytosis was present, but it was not a prominent finding in this case. The patient was treated with Gleevec and achieved a normal CBC, normal bone marrow morphology, as well as complete cytogenetic response by April 2005. However, FISH showed rare cells with PDGFRb/TEL fusion (1.2% of 500 nuclei).

Proposed diagnosis:
Chronic myeloproliferative disorder with t(5;12).

Panel diagnosis:
agree with proposed diagnosis

Comments:

PowerPoint:
Presentation Link

Images:
Case Image 52a.jpg Figure 1
Case Image 52b.jpg Figure 2
Case Image 52c.jpg Figure 3
Case Image 52d.jpg Figure 4
Case Image 52e.jpg Figure 5
Case Image 52f.jpg Figure 6
Case Image 52g.jpg Figure 7
Case Image 52h.jpg Figure 8
Case Image 52i.jpg Figure 9

Back to Top

Back to Cases by Session

Back to Cases by Contact Submitter